These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Methotrexate in juvenile rheumatoid arthritis. Do the benefits outweigh the risks? Giannini EH; Cassidy JT Drug Saf; 1993 Nov; 9(5):325-39. PubMed ID: 8280401 [TBL] [Abstract][Full Text] [Related]
31. Early experiences with auranofin in juvenile rheumatoid arthritis. Brewer EJ; Giannini EH; Person DA Am J Med; 1983 Dec; 75(6A):152-6. PubMed ID: 6419599 [TBL] [Abstract][Full Text] [Related]
32. Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group. Ravelli A; Gerloni V; Corona F; Falcini F; Lepore L; De Sanctis R; Zulian F; Buoncompagni A; Sardella ML; Strano CG; Alessio M; Fantini F; Bardare M; Martini A Clin Exp Rheumatol; 1998; 16(2):181-3. PubMed ID: 9536397 [TBL] [Abstract][Full Text] [Related]
33. Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis. Shetty AK; Zganjar BE; Ellis GS; Ludwig IH; Gedalia A J Pediatr Ophthalmol Strabismus; 1999; 36(3):125-8. PubMed ID: 10358815 [TBL] [Abstract][Full Text] [Related]
34. Methotrexate in rheumatoid arthritis. An update. Bannwarth B; Labat L; Moride Y; Schaeverbeke T Drugs; 1994 Jan; 47(1):25-50. PubMed ID: 7510620 [TBL] [Abstract][Full Text] [Related]